Skip to main content
Glama

Opentargets

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already signal read-only/idempotent/non-destructive behavior, and the description adds substantial behavioral detail beyond that: graceful degradation when GLEIF/OpenFIGI are unavailable, explicit `unresolved` reporting, returning `figi_candidates` on ambiguity, and cascading internal lookups. It discloses exactly what happens in non-happy paths.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is front-loaded with examples and the core purpose, and every major clause carries operational value. However, the heavy nested parentheses and long run-on structure make it denser than necessary; a bit of restructuring would improve scanability without losing information.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries the burden of explaining return behavior, and it does: identifiers are source-labelled, unresolved ones are explicit, ambiguous FIGI matches return candidates, and enrichment failures degrade gracefully. Both supported entity types are covered with their input and output expectations, so an agent has enough to call and interpret the result.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% (baseline 3), but the description adds significant meaning: accepted input forms for both types, the ISIN-to-LEI behavior, and especially the boundary instruction to pass the ENTITY NAME ONLY and never a full noun phrase. This materially prevents incorrect invocation, which the schema alone does not convey.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a specific verb and resource: resolving user-spoken names to canonical/official identifiers needed by other tools. It enumerates supported types (company, drug) and specific identifier outcomes (CIK, ticker, LEI, FIGI, RxCUI), making its role unambiguous even among many siblings.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It gives explicit usage context: 'Use FIRST whenever you have a name but need an ID,' and includes natural-language triggers. It does not explicitly name sibling tools to use instead for non-identifier needs, so it stops short of a full when-not/alternatives statement.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Opentargets toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.9/5.0
Disambiguation2/5

Several clusters of tools overlap heavily: ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, and deep_research all answer data questions; entity_profile, compare_entities, and recent_changes all pull company data; polymarket_edges, polymarket_arbitrage, and bet_research all analyze prediction markets. Though descriptions are detailed, the boundaries are subtle and the beta variant is nearly identical to the stable one.

Naming Consistency3/5

Most names are snake_case, but there's no consistent verb_noun pattern: some are bare nouns (disease, target, drug, search), some are verb phrases (resolve_entity, validate_claim, generate_llms_txt), and some are domain-prefixed (ask_pipeworx_*, polymarket_*, target_*). The mixed conventions make it hard to predict tool names.

Tool Count2/5

38 tools is far beyond the typical well-scoped server, and the set mixes Open Targets lookup, a general data platform (Pipeworx), prediction markets, npm package checks, and AI-marketing utilities under the name 'Opentargets'. Many tools are unrelated to the server's apparent core purpose.

Completeness4/5

The Open Targets drug-discovery workflow is well covered: search for IDs, get disease/drug/target profiles, and get associations/known drugs. However, the broader platform lacks some lifecycle operations (no create/update/delete since it's read-only), and the unrelated utilities (generate_llms_txt, scan_dependency) appear tacked on rather than filling domain gaps.

Resources